These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37306261)

  • 1. Liquid chromatography separation and identification of new oxidative degradation impurity in edoxaban tosylate hydrate drug substance by using liquid chromatography with tandem mass spectrometry.
    Alluri C; Sharma GVR
    Eur J Mass Spectrom (Chichester); 2023 Jun; 29(3):143-158. PubMed ID: 37306261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impurity profile analysis of amphotericin B using on-line two-dimensional high performance liquid chromatography-quadrupole time-of-flight mass spectrometry].
    Weng RW; Wang XT; Wen HL; Liu H
    Se Pu; 2024 Apr; 42(5):432-444. PubMed ID: 38736386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
    Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
    Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MS-Compatible Chromatographic Method for Quantification of Potential Organic Impurities of Elagolix Sodium in Tablet Dosage Form with Identification of Major Degradation Products.
    Desai P; Prajapati R; Chokshi A
    J AOAC Int; 2023 May; 106(3):568-579. PubMed ID: 36721330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.
    Prajapati KJ; Kothari CS
    Chem Res Toxicol; 2022 Jul; 35(7):1206-1219. PubMed ID: 35731702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatographic separation of tiropramide hydrochloride and its degradation products along with their structural characterization using liquid chromatography quadrupole time-of-flight tandem mass spectrometry and nuclear magnetic resonance.
    Tidke M; Golla VM; Kushwah BS; Naik DD; Gananadhamu S
    Biomed Chromatogr; 2023 Aug; 37(8):e5636. PubMed ID: 37005769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Separation and identification of impurities from intermediates of istradefylline].
    Wang Y; Lü X; Xu H; Meng Z; Li J; Xu Z; Xue M
    Se Pu; 2021 Apr; 39(4):430-436. PubMed ID: 34227764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
    Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous quantification of (E) and (Z) isomers of rilpivirine and four degradation products in bulk and tablets by reversed-phase ultra-high-performance liquid chromatography and confirmation of all by molecular weight.
    Mhaske DK; Kumbhar AS
    J Sep Sci; 2023 Jul; 46(13):e2201067. PubMed ID: 37021513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a trap-free two-dimensional liquid chromatography combined with ion trap/time-of-flight mass spectrometry for separation and characterization of impurities and isomers in cefpiramide.
    Wang J; Xu Y; Wen C; Wang Z
    Anal Chim Acta; 2017 Nov; 992():42-54. PubMed ID: 29054149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability-indicating assay method for acotiamide: Separation, identification and characterization of its hydroxylated and hydrolytic degradation products along with a process-related impurity by ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
    Thummar M; Patel PN; Samanthula G; Ragampeta S
    Rapid Commun Mass Spectrom; 2017 Nov; 31(21):1813-1824. PubMed ID: 28836303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation pathways and impurity profiling of the anticancer drug apalutamide by HPLC and LC-MS/MS and separation of impurities using Design of Experiments.
    Lakka NS; Kuppan C; Vadagam N; Reddamoni SY; Muthusamy C
    Biomed Chromatogr; 2023 Feb; 37(2):e5549. PubMed ID: 36409057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LC-HRMS and NMR studies for characterization of forced degradation impurities of ponatinib, a tyrosine kinase inhibitor, insights into in-silico degradation and toxicity profiles.
    Golla VM; Kushwah BS; Dhiman V; Velip L; Samanthula G
    J Pharm Biomed Anal; 2023 Apr; 227():115280. PubMed ID: 36773542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation and characterization of two series of unknown degradation impurities caused by light irradiation and autoclaving in xinfujunsu injection using liquid chromatography tandem mass spectrometry.
    Huang Q; Tang K; Ren X; Wang J
    Rapid Commun Mass Spectrom; 2022 Feb; 36(3):e9223. PubMed ID: 34773922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of prototypical degradation mechanism, characterization of unknown degradation impurities by liquid chromatography-quadrupole-time-of-flight-tandem mass spectrometry and stability-indicating analytical method of selumetinib.
    Mishra S; Rajput N; Jadav T; Panday NK; Sahu AK; Sengupta P
    Biomed Chromatogr; 2024 Jan; 38(1):e5761. PubMed ID: 37920143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LC-ESI-QTOF-MS analysis utilizing gas-phase fragmentation reactions subjected to ESI-IS-CID and ESI-CID-MS/MS conditions to study the degradation behaviour of sorafenib tosylate: NMR and in vitro cytotoxicity and apoptosis detection studies of hydrolytic degradation products.
    Johnsirani P; Wani AA; Bharatam PV; Nanjappan S
    J Pharm Biomed Anal; 2020 Jan; 177():112881. PubMed ID: 31542419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of seven new related impurities and forced degradation products of tetracaine hydrochloride and proposal of degradation pathway by UHPLC-Q-TOF-MS.
    Liu C; Luo Y; Tao Q; Hong L; Zeng S
    J Pharm Biomed Anal; 2023 Jan; 223():115116. PubMed ID: 36343535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation and characterization of allergenic polymerized impurities from cephalosporin for injection by trap free two-dimensional high performance size exclusion chromatography × reversed phase liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
    Xu Y; Wang D; Zhu B; Tang L; Wang J
    J Pharm Biomed Anal; 2018 May; 154():425-432. PubMed ID: 29579634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.